Immunovant (IMVT) Selling, General & Administrative (2018 - 2026)
Immunovant (IMVT) recorded Selling, General & Administrative of $17.69 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 32.0% from $26.02 million a year earlier but up 2.5% from the prior quarter.
Immunovant (IMVT) Selling, General & Administrative (2018 - 2026) Analysis & Trends
On a TTM basis, Immunovant's Selling, General & Administrative came in at $67.91 million as of Jun 30, 2026, down 19.6% year-over-year; for FY2026 (ended Mar 31, 2026), it was $76.24 million, down 1.3% from FY2025.
- Annual Selling, General & Administrative has a five-year compound annual growth rate of 14.0% (FY2021 to FY2026).
- Across earlier fiscal years, Selling, General & Administrative came in at $77.24 million in FY2025 (+34.8%), $57.28 million in FY2024 (+19.3%), $48.02 million in FY2023 (-11.4%) and $54.23 million in FY2022 (+37.2%).
- Quarterly Selling, General & Administrative has ranged from $11.52 million in fiscal Q3 2022 to $26.02 million in fiscal Q1 2026 over the past five years.
- On a year-over-year basis, Selling, General & Administrative has declined for four consecutive quarters, with growth averaging 10.5% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 81.0% in fiscal Q2 2022, against a decline of 32.0% in fiscal Q1 2027 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $17.27 million (Q4 2026), $15.44 million (Q3 2026) and $17.51 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Immunovant | 6.94 Bn | 6.94 Bn | - | 17.69 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.69 Mn |
| Mar 31, 2026 | 17.27 Mn |
| Dec 31, 2025 | 15.44 Mn |
| Sep 30, 2025 | 17.51 Mn |
| Jun 30, 2025 | 26.02 Mn |
| Mar 31, 2025 | 20.17 Mn |
| Dec 31, 2024 | 19.78 Mn |
| Sep 30, 2024 | 18.47 Mn |
| Jun 30, 2024 | 18.81 Mn |
| Mar 31, 2024 | 14.82 Mn |
| Dec 31, 2023 | 13.22 Mn |
| Sep 30, 2023 | 13.84 Mn |
| Jun 30, 2023 | 15.40 Mn |
| Mar 31, 2023 | 12.42 Mn |
| Dec 31, 2022 | 11.78 Mn |
| Sep 30, 2022 | 11.88 Mn |
| Jun 30, 2022 | 11.95 Mn |
| Mar 31, 2022 | 15.24 Mn |
| Dec 31, 2021 | 11.52 Mn |
| Sep 30, 2021 | 16.29 Mn |
Immunovant Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();